Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

July 29, 2016

Greguy Dorce v. Cytrx Corporation et al

Track this case

Case Number:

2:16-cv-05666

Court:

California Central

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

S. James Otero

Firms

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 01, 2016

    CytRx Hit With 2nd Investor Suit Over Cancer Drug Trial

    Investors in the biopharmaceutical company CytRx Corp. on Friday filed a second potential class action against the company for allegedly concealing the negative effects of a hold the U.S. Food and Drug Administration placed on clinical trials for the cancer drug aldoxorubicin.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login